U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866782) titled 'European Registry of Next Generation Imaging in Advanced Prostate Cancer' on Feb. 26.
Brief Summary: The RING study is a European registry collecting real-world data on advanced prostate cancer (APC) imaging. It aims to evaluate the role of next-generation imaging (NGI), such as PET/CT and whole-body MRI, in detecting and monitoring the disease compared to conventional imaging.
Men aged 18 or older with histologically confirmed prostate cancer are eligible to participate in the study if they require imaging to assess potential metastases, either at diagnosis or after relapse and sign a consent form.
Patients will receive standard...